2024 #RAREis Global Advocate Grant Recipient

We’re honored to announce that we’ve been selected as a 2024 RAREis Global Advocate Grant recipient by Amgen’s RAREis program.

This recognition underscores our unwavering commitment to the Glanzmann’s Thrombasthenia community and the rare disease community at large, who inspire us every day with their strength and resilience amid care and research barriers.

With this RAREisGrant, we’re motivated to continue pursuing a cure as we raise awareness and expand our efforts in education and advocacy for all those living with Glanzmann’s Thrombasthenia and their loved ones.

Learn more here: https://bit.ly/3Z6sfSP